Publikation

Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.

Wissenschaftlicher Artikel/Review - 01.07.2023

Bereiche
PubMed
DOI
Kontakt

Zitation
Filippidis P, Damas J, Viala B, Assal F, Tshikung O, Tarr P, Derfuss T, Oberholzer M, Jelcic I, Hundsberger T, Sacco L, Cavassini M, Du Pasquier R, Darling K, NAMACO Study Group, Swiss HIV Cohort Study. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study. J Acquir Immune Defic Syndr 2023; 93:219-228.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
J Acquir Immune Defic Syndr 2023; 93
Veröffentlichungsdatum
01.07.2023
eISSN (Online)
1944-7884
Seiten
219-228
Kurzbeschreibung/Zielsetzung

Despite modern antiretroviral therapy, human immunodeficiency virus-1 (HIV-1) ribonucleic acid (RNA) escape into the cerebrospinal fluid (CSF) may occur. We examined the prevalence of and factors associated with CSF HIV-1 escape among people living with HIV (PLWH) in Switzerland.